CD209 and neoplasm: Dioscin treatment (30 mg/kg and 60 mg/kg) decreased the population of F4/80+CD209+ macrophages that infiltrated tumour cells (5.03 ± 0.62% and 5.66 ± 0.37% vs 7.71 ± 0.61%, respectively, both P < 0.05).